Exhibit 10.14
MAZE THERAPEUTICS, INC.
[Date]
[Name]
Sent via email
RE: Continued Employment with Maze Therapeutics Inc.
Dear [Name]:
This letter agreement sets forth the terms confirms your continued employment as [ ] of Maze Therapeutics, Inc., a Delaware Corporation (the “Company”). [CEO - You will continue to report to the Board of Directors of the Company (the “Board”) and will remain a member of the Board.] [Other – You will continue to report to the Company’s Chief Executive Officer.] This letter agreement amends and restates the employment offer letter entered into between you and the Company, dated [ ] (the “Prior Agreement”).
1. Compensation.
a. Salary. In this position, the Company will pay you an annual base salary of $[ ] per year, payable in accordance with the Company’s standard payroll schedule. Your pay will be periodically reviewed as a part of the Company’s regular reviews of compensation.
b. Bonus. You will be eligible to receive a cash incentive annual bonus of up to [ ]% of your base salary, based upon the achievement of both Company and individual goals. Any annual bonus earned will be paid no later than March 15th of the year following the year in which such bonus was earned. Please note that bonus programs, payouts and criterion are subject to change or adjustment as the business needs at the Company may require.
c. Equity Awards. You currently hold Company equity grants. You will be eligible for future discretionary equity grants at the sole discretion of the Company.
2. Employee Benefits. You will be entitled to participate in employee benefit plans currently and hereafter maintained by the Company of general applicability to other employees of the Company subject to the eligibility requirements of each such benefit plan. The Company, in its sole discretion, may amend, suspend or terminate its employee benefits at any time, with or without notice. In addition, you will be entitled to vacation in accordance with the Company’s vacation policy, as in effect from time to time. We also acknowledge that you are a participant in, or will become a participant in, the Company’s Amended and Restated Executive Severance and Change in Control Plan (the “A&R Executive Severance and Change in Control Plan”).
3. Confidentiality Agreement. By signing this letter agreement, you reaffirm the terms and conditions of the confidential information and invention assignment agreement by and between you and the Company.
4. No Conflicting Obligations. You understand and agree that by signing this letter agreement, you represent to the Company that your performance will not breach any other agreement to which you are a party and that you have not, and will not during the term of your employment with the Company, enter into